Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections

NCT00685698 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Infections

Interventions

DRUG: TG-873870 (Nemonoxacin)

Sponsor

TaiGen Biotechnology Co., Ltd.